RosetteSep™ Human Multiple Myeloma Cell Enrichment Cocktails

: STEMCELL Technologies

RosetteSep™ Human Multiple Myeloma Cell Enrichment Cocktails

: STEMCELL Technologies

Immunodensity isolation of untouched plasma cells for multiple myeloma research.

Fast and easy-to-use
Requires no special equipment or training
Untouched, viable cells

The RosetteSep™ Human Multiple Myeloma Cell Enrichment Cocktail is designed to enrich multiple myeloma cells (B cell and plasma cells) from fresh bone marrow aspirates by negative selection. Unwanted cells are targeted for removal with Tetrameric Antibody Complexes recognising CD2, CD14, CD33, CD41, CD45RA, CD66b and glycophorin A on red blood cells (RBCs). When centrifuged over a buoyant density medium such as Lymphoprep™ (STMC07801), the unwanted cells pellet along with the RBCs. The purified multiple myeloma cells are present as a highly enriched population at the interface between the plasma and the buoyant density medium.

: Product Restrictions: (i) Customer shall not make products or any portion of them, in any way, shape or form, including as a component of another product available for the purpose of further resale or alter or remove the Product label and the Supplier’s mark of origin without express written permission of Supplier; and (ii) Customer is familiar with Supplier’s restrictions on the use of the Products and shall use the Products in compliance with such restrictions and the applicable Supplier Product Information sheet (collectively, the ‘Product Restrictions’).